| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
TCMD Stock Overview
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.
Rewards
Risk Analysis
No risks detected for TCMD from our risk checks.
Tactile Systems Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.54 |
| 52 Week High | US$46.41 |
| 52 Week Low | US$6.28 |
| Beta | 1.45 |
| 1 Month Change | -15.09% |
| 3 Month Change | -1.31% |
| 1 Year Change | -82.77% |
| 3 Year Change | -81.78% |
| 5 Year Change | -76.36% |
| Change since IPO | -31.95% |
Recent News & Updates
Tactile Systems Technology GAAP EPS of -$0.23 misses by $0.09, revenue of $59.6M beats by $2.72M
Tactile Systems Technology press release (NASDAQ:TCMD): Q2 GAAP EPS of -$0.23 misses by $0.09. Revenue of $59.6M (+16.6% Y/Y) beats by $2.72M. Non-GAAP net loss of $2.9 million, compared to non-GAAP net income of $2.0 million in second quarter of 2021. The Company now expects full year 2022 total revenue in the range of $238.0 million to $242.0 million ($237.35M consensus), representing growth of approximately 14% to 16% year-over-year, compared to total revenue of $208.1 million in 2021. The Company’s prior 2022 revenue guidance expectations called for total revenue in the range of $235.0 million to $240.0 million, representing growth of approximately 13% to 15% year-over-year.
Shareholder Returns
| TCMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -8.7% | -7.2% | -6.9% |
| 1Y | -82.8% | -32.3% | -23.7% |
Return vs Industry: TCMD underperformed the US Medical Equipment industry which returned -32.3% over the past year.
Return vs Market: TCMD underperformed the US Market which returned -23.7% over the past year.
Price Volatility
| TCMD volatility | |
|---|---|
| TCMD Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: TCMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: TCMD's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 988 | Dan Reuvers | https://www.tactilemedical.com |
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Tactile Systems Technology, Inc. Fundamentals Summary
| TCMD fundamental statistics | |
|---|---|
| Market Cap | US$151.80m |
| Earnings (TTM) | -US$31.06m |
| Revenue (TTM) | US$221.85m |
0.7x
P/S Ratio-4.9x
P/E RatioIs TCMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TCMD income statement (TTM) | |
|---|---|
| Revenue | US$221.85m |
| Cost of Revenue | US$62.99m |
| Gross Profit | US$158.86m |
| Other Expenses | US$189.92m |
| Earnings | -US$31.06m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 07, 2022
| Earnings per share (EPS) | -1.54 |
| Gross Margin | 71.61% |
| Net Profit Margin | -14.00% |
| Debt/Equity Ratio | 44.1% |
How did TCMD perform over the long term?
See historical performance and comparison